Moving to another Question 20 On October 1, 2020, Company A purchased a patent for a new drug for $7,200,000. Due to the competitive nature of the product, the patent was estimated to have a useful life of 10 years with no residual value. On January 1, 2023, Company A spent $200,000 in legal fees for a successful defense of the patent. 

What amount should Company A report approximately as amortization expense for 2023?